Todd Harris
Gründer bei TYRA BIOSCIENCES, INC.
Vermögen: 23 Mio $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von Todd Harris
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 23 | |
| Public Company | Pharmaceuticals: Major | 19 | |
Primmune Therapeutics, Inc.
 Primmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Primmune Therapeutics, Inc. develops small molecules, orally administered toll-like receptor for cancer immunotherapy and tumors. The firm offers treatment and prevention of viral infections. The company was founded by Paulo Rangel, James Appleman, and Stephen Webber in October, 2017 and is headquartered in San Diego, CA.
8
| Holding Company | Miscellaneous Commercial Services | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Todd Harris
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| ALLERGAN, INC. | Pharmaceuticals: Major | Public Communications Contact Public Communications Contact Corporate Officer/Principal Director/Board Member General Counsel | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Operating Officer Corporate Officer/Principal Chief Administrative Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| CELGENE | Biotechnology | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MEDICIS PHARMACEUTICAL CORP | Pharmaceuticals: Major | Director of Finance/CFO General Counsel | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Investor Relations Contact Chief Tech/Sci/R&D Officer | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Founder Private Equity Investor Private Equity Investor | |
ARCH Venture Partners LP
 ARCH Venture Partners LP Investment ManagersFinance Part of ARCH Venture Partners LLC, ARCH Venture Partners LP operates as a venture capital firm. The company is based in Dover, DE. The company was founded by Robert Taylor Nelsen. | Investment Managers | Founder Corporate Officer/Principal | |
| GENELUX CORPORATION | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
NovaCardia, Inc.
 NovaCardia, Inc. Pharmaceuticals: MajorHealth Technology NovaCardia, Inc. develops drugs to treat cardiovascular diseases. The company provides treatment for the patients by developing and commercializing clinical stage drug diseases. It also develops small molecule drugs. the company was founded in November, 2001 by Eckard Weber & Howard C. Dittrich and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| KYTHERA BIOPHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Founder Director of Finance/CFO Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer General Counsel Comptroller/Controller/Auditor | |
| ANAPTYSBIO, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| RECEPTOS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Founder | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Doctorate Degree | |
| University of Oxford | College/University | Graduate Degree Graduate Degree | |
| University of Medicine & Dentistry of New Jersey | College/University | Corporate Officer/Principal Doctorate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree Doctorate Degree | |
| San Diego State University | College/University | Graduate Degree Graduate Degree | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Undergraduate Degree | |
| Rensselaer Polytechnic Institute | College/University | Undergraduate Degree Undergraduate Degree | |
| University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Graduate Degree Undergraduate Degree Doctorate Degree | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| California Society of Certified Public Accountants | Corporate Officer/Principal Corporate Officer/Principal | ||
| FATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Executive Officer | |
Dompe Biotec SpA
 Dompe Biotec SpA Pharmaceuticals: MajorHealth Technology Dompe Biotec SpA (Dompé Biotec SpA) provides biotechnological drugs. Its products are used for the treatment of haematology, infectious diseases, nephrology, oncology, transfusion units and neuro-oncology. The company was founded in 1988 and is headquartered in Milan, Italy | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Amgen Europe BV
 Amgen Europe BV Medical DistributorsDistribution Services Part of Amgen, Inc., Amgen Europe BV wholesales pharmaceutical products. The company is based in Breda, Netherlands. | Medical Distributors | Corporate Officer/Principal Director of Finance/CFO | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
AgBiome INC
 AgBiome INC BiotechnologyHealth Technology AgBiome LLC provides early stage research and discovery to the agriculture industry. It develops biological product that controls the predominant soil-borne diseases of greenhouse and major row crops. The firm applies genomics and screening technologies to identify plant-associated microbes that enhance plant health, pest resistance, and yield. The company was founded by Jeff Dangl, John N. Couch, Paul Schulze-Lefert, Scott J. Uknes, John Ryals, Eric R. Ward, and Mike Koziel in 2012 and is headquartered in Research Triangle Park, NC. | Biotechnology | Director/Board Member Director/Board Member | |
eFFECTOR Therapeutics Operations, Inc.
 eFFECTOR Therapeutics Operations, Inc. Miscellaneous Commercial ServicesCommercial Services eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA. | Miscellaneous Commercial Services | Director/Board Member Founder Founder | |
| Harvard Business School | College/University | Graduate Degree Masters Business Admin Masters Business Admin Masters Business Admin | |
| CIDARA THERAPEUTICS, INC. | Pharmaceuticals: Other | Director/Board Member Corporate Officer/Principal | |
| Anderson School of Management | College/University | Masters Business Admin Masters Business Admin | |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| UNITY BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member Chairman Director of Finance/CFO Comptroller/Controller/Auditor | |
CinRx Pharma LLC
 CinRx Pharma LLC Pharmaceuticals: MajorHealth Technology CinRx Pharma LLC develops biopharmaceutical products. It provides therapeutics in a novel way that meets the modern paradigm of drug development. The company was founded by Jonathan L. Isaacsohn in 2015 and is headquartered in Cincinnati, OH. | Pharmaceuticals: Major | Director-Back Office Operation Chief Tech/Sci/R&D Officer | |
| VIR BIOTECHNOLOGY, INC. | Biotechnology | Director/Board Member Founder Director/Board Member | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Director/Board Member Director/Board Member | |
| ARCUTIS BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| EQUILLIUM, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Mbrace Therapeutics, Inc.
 Mbrace Therapeutics, Inc. BiotechnologyHealth Technology Mbrace Therapeutics, Inc. is an American company that specializes in antibody discovery methodology. The company's approach, called SPARTA, overcomes several challenges to generate human antibodies that can be quickly translated into clinical applications. Mbrace Therapeutics was founded by Renata Pasqualini, Isan Chen, and Wadih Arap, with Isan Chen serving as the CEO since incorporation. | Biotechnology | Director/Board Member Founder | |
| NEUMORA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Statistik
International
| Vereinigte Staaten | 46 |
| Italien | 3 |
| Vereinigtes Königreich | 2 |
| Niederlande | 2 |
Sektoral
| Health Technology | 30 |
| Consumer Services | 11 |
| Finance | 4 |
| Commercial Services | 4 |
| Energy Minerals | 2 |
Operativ
| Director/Board Member | 322 |
| Corporate Officer/Principal | 87 |
| Independent Dir/Board Member | 85 |
| Undergraduate Degree | 38 |
| Director of Finance/CFO | 34 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Robert Nelsen | 80 |
| Amir Nashat | 49 |
| Nina Kjellson | 49 |
| Robert More | 42 |
| Kristina Burow | 40 |
| Dennis Fenton | 28 |
| Keith Leonard | 20 |
| John Smither | 20 |
| Scott Morenstein | 17 |
| Alan Fuhrman | 17 |
| Richard Peterson | 13 |
| Gilla Kaplan | 12 |
| Esther van den Boom | 12 |
| Erle T. Mast | 11 |
| Jake Simson | 11 |
- Börse
- Insiders
- Todd Harris
- Unternehmensverbindungen
